Cargando…

Drospirenone and mood

Detalles Bibliográficos
Autor principal:	Zuschmann, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	NPS MedicineWise 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427626/ https://www.ncbi.nlm.nih.gov/pubmed/36110170 http://dx.doi.org/10.18773/austprescr.2022.048

Ejemplares similares

Vitamin D serum levels in women using contraception containing drospirenone – a preliminary study
por: Ciebiera, Michał, et al.
Publicado: (2017)

Illumination and mood
por: Kripke, Daniel
Publicado: (2010)

The benefits of estetrol addition to drospirenone for contraception
por: Foidart, Jean Michel, et al.
Publicado: (2023)

Estetrol/Drospirenone: A Review in Oral Contraception
por: Lee, Arnold, et al.
Publicado: (2022)

Pharmacokinetics of drospirenone and ethinylestradiol in Caucasian and Japanese women
por: Blode, Hartmut, et al.
Publicado: (2012)

Preparation and Evaluation of Intravaginal Ring Containing Drospirenone
por: Zhang, Ying, et al.
Publicado: (2013)

Latitude, light, clocks and mood
por: Erren, Thomas C, et al.
Publicado: (2011)

Correction: Estetrol/Drospirenone: A Review in Oral Contraception
por: Lee, Arnold, et al.
Publicado: (2022)

Lithium not only stabilizes mood, it is also neuroprotective
por: Praharaj, Samir Kumar
Publicado: (2011)

Organic mood disorder: Sequelae of small vessel disease
por: Shejekar, Shradha, et al.
Publicado: (2019)

Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome
por: Mathur, Ruchi, et al.
Publicado: (2008)

The association between drospirenone and hyperkalemia: a comparative-safety study
por: Bird, Steven T, et al.
Publicado: (2011)

Statin and Aspirin Use and the Risk of Mood Disorders among Men
por: Williams, Lana J., et al.
Publicado: (2016)

Comment on “Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status“
por: Pappagallo, Marco, et al.
Publicado: (2022)

EE-drospirenone-levomefolate calcium versus EE-drospirenone + folic acid: folate status during 24 weeks of treatment and over 20 weeks following treatment cessation
por: Diefenbach, Konstanze, et al.
Publicado: (2013)

Low Thrombin Generation in Users of a Contraceptive Containing Estetrol and Drospirenone
por: Morimont, Laure, et al.
Publicado: (2022)

Drospirenone-containing oral contraceptives and venous thromboembolism: an analysis of the FAERS database
por: Madigan, David, et al.
Publicado: (2018)

Headache and anxiety/mood disorders: are we trapped in a cul-de-sac?
por: Galli, Federica
Publicado: (2017)

Vortioxetine-induced manic mood switch in patient with previously unknown bipolar disorder
por: Sobreira, Gonçalo, et al.
Publicado: (2017)

Atypical Mood Symptoms as the Presenting Feature of Moyamoya Disease: A Case Report
por: Navkhare, Praveen N, et al.
Publicado: (2020)

A single-arm study to evaluate the transfer of drospirenone to breast milk after reaching steady state, following oral administration of 4 mg drospirenone in healthy lactating female volunteers
por: Melka, Dace, et al.
Publicado: (2020)

Extracorporeal membrane oxygenation in pregnancy: details on novel therapies and cardiac, preeclampsia, and mood disorder complications
por: Yin, Ophelia, et al.
Publicado: (2022)

Effect of High-intensity Intermittent Training Program on Mood State in Overweight/Obese Young Men
por: OUERGHI, Nejmeddine, et al.
Publicado: (2016)

May confusion be a misleading initial clinical presentation of COVID-19 in individuals with mood disorders?
por: Vorspan, Florence, et al.
Publicado: (2021)

Efficacy and safety of combined ethinyl estradiol/drospirenone oral contraceptives in the treatment of acne
por: Tan, Jerry KL, et al.
Publicado: (2010)

Antiandrogenic and antimineralocorticoid health benefits of COC containing newer progestogens: dienogest and drospirenone
por: Regidor, Pedro-Antonio, et al.
Publicado: (2017)

The influence of hormone therapy with drospirenone-estradiol on endometrioid type endometrial cancer patients
por: Lim, Soyi, et al.
Publicado: (2018)

Childhood dissociation as a precursor of mood disorder: A 5 years follow-up case study
por: Bhattacharya, Arnab, et al.
Publicado: (2015)

Mixed mood states and emotion-related urgency in bipolar spectrum disorders: a call for greater investigation
por: Jaggers, Jennie A., et al.
Publicado: (2020)

Linking peripheral CD8(+) single‐cell transcriptomic characteristics of mood disorders underlying with the pathological mechanism
por: Lu, Jing, et al.
Publicado: (2021)

Treatment of premenstrual dysphoric disorder (PMDD) with a novel formulation of drospirenone and ethinyl estradiol
por: De Berardis, Domenico, et al.
Publicado: (2007)

Effect and safety of drospirenone and ethinylestradiol tablets (II) for dysmenorrhea: A systematic review and meta-analysis
por: Shi, Jinghua, et al.
Publicado: (2022)

Comparative actions of progesterone, medroxyprogesterone acetate, drospirenone and nestorone on breast cancer cell migration and invasion
por: Fu, Xiao-Dong, et al.
Publicado: (2008)

Safety, efficacy and patient acceptability of drospirenone and estradiol in the treatment of menopausal vasomotor symptoms: a review
por: Carranza-Lira, Sebastián
Publicado: (2009)

Evaluation of Apelin and Insulin Resistance in Patients with PCOS and Therapeutic Effect of Drospirenone-Ethinylestradiol Plus Metformin
por: Sun, Xianchang, et al.
Publicado: (2015)

Pharmacological and metabolic effects of drospirenone as a progestin-only pill compared to combined formulations with estrogen
por: Regidor, Pedro-Antonio, et al.
Publicado: (2023)

A Comparative Efficacy of Low-Dose Combined Oral Contraceptives Containing Desogestrel and Drospirenone in Premenstrual Symptoms
por: Wichianpitaya, Jirath, et al.
Publicado: (2013)

Efficacy and safety of a 24-day regimen of drospirenone-containing combined oral contraceptive in Korean women
por: Kim, Nayoung, et al.
Publicado: (2015)

Multicenter, phase III trials on the contraceptive efficacy, tolerability and safety of a new drospirenone‐only pill
por: Palacios, Santiago, et al.
Publicado: (2019)

Safety, efficacy, actions, and patient acceptability of drospirenone/ethinyl estradiol contraceptive pills in the treatment of premenstrual dysphoric disorder
por: Breech, Lesley L, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ft6du2r6e05so6cp0bc1d64ur6